Despite having lost two of its strongest voices on IP in the last two years, the high court is wading into some 'meat and potatoes' IP issues such as pharma patents and copyright fair use.
December 30, 2022 at 06:22 PM
10 minute read
The original version of this story was published on National Law Journal
All eyes will be on the Supreme Court in 2023 when it comes to intellectual property.
After a few relatively quiet years for IP, the high court is expected to hear arguments in a high-stakes biopharma patent case and two trademark cases that will include a hard look at the framework for balancing expressive content against trademark rights.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
The U.S. Supreme Court will be tackling “meat and potatoes” IP issues in 2023 without one of its strongest voices in the subject area, retired Justice Stephen Breyer. (Photo: Diego M. Radzinschi/ALM)
